T J R Sons Ltd's Insider Trades & SAST Disclosures
T J R Sons Ltd's most recent trade in Aurobindo Pharma Ltd. was a Revoke of 3,750,000 Equity Shares done at an average price of Rs. 469.3 . Disclosure was reported to the exchange on Feb. 28, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
T J R Sons Ltd's has made SAST transactions in Aurobindo Pharma Ltd. recently where a Pledge of 3,090,000 shares done . Disclosure was reported to the exchange on Oct. 12, 2020.
Add Superstar Alert
Share
Note
This is a custom search result for pattern T J R Sons Ltd.To see full superstar portfolios of large investors like Jhunjhunwala, Damani and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | Axis Clinicals, Trident Chemphar Ltd, RPR Sons Advisors Pvt Ltd Jointly holding | Promoter | Pledge | 24 Dec 2024 | 3,090,000 | 10,000 | - | - | 08 Oct 2020 08 Oct 2020 |
SAST (Reg31) | - | Release | |
| Aurobindo Pharma | Axis Clinicals Limited (jointly holding with Trident Chemphar Limited and RPR Sons Advisors Pvt.Ltd) | Promoter | Pledge | 24 Dec 2024 | 3,400,000 | 3,410,000 | - | - | 17 Feb 2021 17 Feb 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Limited Trident Chemphar Limited and RPR Sons Advisors Pvt.Ltd Joint Holding | Promoter | Pledge | 24 Dec 2024 | 300,000 | 3,710,000 | - | - | 23 Mar 2021 23 Mar 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd. Trident Chemphar Ltd. RPR Sons Advisors Pvt. Ltd. (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 3,600,000 | 110,000 | - | - | 05 Apr 2021 05 Apr 2021 |
SAST (Reg31) | - | Release | |
| Aurobindo Pharma | Axis Clinicals Ltd. Trident Chemphar Ltd. RPR Sons Advisors Pvt. Ltd. (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 2,000,000 | 2,110,000 | - | - | 05 Jul 2021 05 Jul 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 1,250,000 | 3,350,000 | - | - | 09 Jul 2021 09 Jul 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 10,000 | 2,100,000 | 0% | - | 08 Jul 2021 08 Jul 2021 |
SAST (Reg31) | - | Release | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 2,630,000 | 5,980,000 | - | - | 11 Aug 2021 11 Aug 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 120,000 | 6,500,000 | - | - | 13 Aug 2021 13 Aug 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 400,000 | 6,380,000 | - | - | 13 Aug 2021 13 Aug 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 205,000 | 6,970,000 | - | - | 16 Aug 2021 16 Aug 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd Trident Chemphar Ltd and RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 265,000 | 6,765,000 | - | - | 16 Aug 2021 16 Aug 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd. Trident Chemphar Ltd. RPR Sons Advisors Pvt. Ltd. (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 4,000,000 | 2,970,000 | - | - | 23 Nov 2021 23 Nov 2021 |
SAST (Reg31) | - | Release | |
| Aurobindo Pharma | Axis Clinicals Ltd. Trident Chemphar Ltd. RPR Sons Advisors Pvt. Ltd. (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 3,750,000 | 6,720,000 | - | - | 23 Nov 2021 23 Nov 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Clinicals Ltd. Trident Chemphar Ltd. RPR Sons Advisors Pvt. Ltd. (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 151,000 | 6,871,000 | - | - | 23 Nov 2021 23 Nov 2021 |
SAST (Reg31) | - | Creation | |
| Aurobindo Pharma | Axis Cliniclas Ltd. Trident Chemphar Ltd RPR Sons Advisors Pvt Ltd (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 15,000 | 6,856,000 | 0% | - | 30 Nov 2021 30 Nov 2021 |
SAST (Reg31) | - | Release | |
| Aurobindo Pharma | Axis Clinicals Ltd. Trident Chemphar Ltd. RPR Sons Advisors Pvt. Ltd. (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 3,106,000 | 3,750,000 | - | - | 18 Jan 2022 18 Jan 2022 |
SAST (Reg31) | - | Release | |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 28 Feb 2023 | 3,750,000 | 16,726,716 (2.85%) | 0.64% | 469.3 | 1,759,687,500 | 24 Feb 2023 24 Feb 2023 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 19 Jan 2022 | 3,106,000 | 16,726,716 (2.85%) | 0.53% | 668.8 | 2,077,292,800 | 18 Jan 2022 18 Jan 2022 |
Insider Trading | Equity Shares | Pledge Released |
| Kanel Industries | T J R Sons Ltd | Promoter | Disposal | 03 Jan 2022 | 555,904 | - | 3.02% | - | 30 Dec 2021 30 Dec 2021 |
SAST (29(2)) | - | Inter-se Transfer | |
| Kanel Industries | T J R Sons Ltd & Dhiren K Thakkar | Promoter | Disposal | 03 Jan 2022 | 555,904 | - | 3.02% | - | 30 Dec 2021 30 Dec 2021 |
SAST (29(2)) | - | Inter-se Transfer | |
| Dharti Proteins | T J R Sons Ltd | Promoter | Disposal | 01 Jan 2022 | 9,000 | - | 0.09% | - | 30 Dec 2021 30 Dec 2021 |
SAST (29(2)) | - | Inter-se Transfer | |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 01 Dec 2021 | 15,000 | 16,726,716 (2.85%) | 0.00% | 660.3 | 9,903,750 | 30 Nov 2021 30 Nov 2021 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 26 Nov 2021 | 151,000 | 16,726,716 (2.85%) | 0.03% | 651.0 | 98,293,450 | 23 Nov 2021 23 Nov 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 26 Nov 2021 | 3,750,000 | 16,726,716 (2.85%) | 0.64% | 651.0 | 2,441,062,500 | 23 Nov 2021 23 Nov 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 26 Nov 2021 | 4,000,000 | 16,726,716 (2.85%) | 0.68% | 651.0 | 2,603,800,000 | 23 Nov 2021 23 Nov 2021 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 19 Aug 2021 | 205,000 | 16,726,716 (2.85%) | 0.03% | 738.1 | 151,300,250 | 16 Aug 2021 16 Aug 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 19 Aug 2021 | 265,000 | 16,726,716 (2.85%) | 0.05% | 738.1 | 195,583,250 | 16 Aug 2021 16 Aug 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 17 Aug 2021 | 120,000 | 16,726,716 (2.85%) | 0.02% | 761.3 | 91,356,000 | 13 Aug 2021 13 Aug 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 17 Aug 2021 | 400,000 | 16,726,716 (2.85%) | 0.07% | 761.3 | 304,520,000 | 13 Aug 2021 13 Aug 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 16 Aug 2021 | 2,630,000 | 16,726,716 (2.85%) | 0.45% | 856.5 | 2,252,595,000 | 11 Aug 2021 11 Aug 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 12 Jul 2021 | 1,250,000 | 16,726,716 (2.85%) | 0.21% | 948.7 | 1,185,875,000 | 09 Jul 2021 09 Jul 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 12 Jul 2021 | 10,000 | 16,726,716 (2.85%) | 0.00% | 951.3 | 9,512,500 | 08 Jul 2021 08 Jul 2021 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 07 Jul 2021 | 2,000,000 | 16,726,716 (2.85%) | 0.34% | 1002.6 | 2,005,200,000 | 05 Jul 2021 05 Jul 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 06 Apr 2021 | 3,600,000 | 16,726,716 (2.85%) | 0.61% | 882.2 | 3,175,920,000 | 05 Apr 2021 05 Apr 2021 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 26 Mar 2021 | 300,000 | 16,726,716 (2.85%) | 0.05% | 846.2 | 253,845,000 | 23 Mar 2021 23 Mar 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 17 Feb 2021 | 3,400,000 | 16,726,716 (2.85%) | 0.58% | 932.2 | 3,169,480,000 | 15 Feb 2021 15 Feb 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) (Revised) | Promoter Group | Revoke | 21 Dec 2020 | 3,090,000 | 16,726,716 (2.85%) | 0.53% | 837.8 | 2,588,647,500 | 08 Oct 2020 08 Oct 2020 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 12 Oct 2020 | 3,090,000 | 16,726,716 (2.85%) | 0.53% | 837.8 | 2,588,647,500 | 08 Oct 2020 08 Oct 2020 |
Insider Trading | Equity Shares | Pledge Released |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.